Philippe Solal Celigny

Philippe Solal Celigny

UNVERIFIED PROFILE

Are you Philippe Solal Celigny?   Register this Author

Register author
Philippe Solal Celigny

Philippe Solal Celigny

Publications by authors named "Philippe Solal Celigny"

Are you Philippe Solal Celigny?   Register this Author

50Publications

1760Reads

6Profile Views

A retrospective study on the management of patients with rituximab refractory follicular lymphoma.

Br J Haematol 2018 01 12;180(2):217-223. Epub 2017 Dec 12.

University hospital, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15023DOI Listing
January 2018

ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies.

Clin Lymphoma Myeloma Leuk 2017 06 10;17(6):362-369.e2. Epub 2017 May 10.

Institut de Cancérologie de l'Ouest René Gauducheau, Saint Herblain, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.05.002DOI Listing
June 2017

Rituximab by subcutaneous route.

Expert Rev Hematol 2015 Apr;8(2):147-53

Institut de Cancérologie de l'Ouest, Saint-Herblain, Bld Jacques Monod 44805 Saint-Herblain Cedex, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/17474086.2015.10
Publisher Site
http://dx.doi.org/10.1586/17474086.2015.1024651DOI Listing
April 2015

t(14;18) Translocation: A predictive blood biomarker for follicular lymphoma.

J Clin Oncol 2014 May 31;32(13):1347-55. Epub 2014 Mar 31.

Sandrine Roulland, Ester Morgado, Stéphanie Sungalee, Nathalie Jouve, and Bertrand Nadel, Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM) U1104, and Centre National de la Recherche Scientifique (CNRS) Unités Mixtes de Recherche (UMR) 7280, Marseille; Philippe Solal-Celigny, Jean Bernard Center, Le Mans; Philippe Colombat, Bretonneau University Hospital, Tours; Françoise Clavel-Chapelon, INSERM U1018 Centre de Recherche en Epidémiologie et Santé des Populations, Villejuif; Pietro Ferrari and Isabelle Romieu, International Agency for Research on Cancer, Lyon; Gilles Salles, Hospices Civils de Lyon, Université de Lyon, UMR CNRS 5239, Pierre Bénite, France; Rachel S. Kelly, Petra H.M. Peeters, Roel Vermeulen, Elio Riboli, and Paolo Vineis, School of Public Health, Imperial College London, London; Kay-Tee Khaw, University of Cambridge; Nick Wareham, Institute of Metabolic Science, Cambridge; Timothy J. Key and Ruth C. Travis, University of Oxford, Oxford, United Kingdom; Domenico Palli, Istituto per lo Studio e la Prevenzione Oncologica, Florence; Valeria Pala, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan; Rosario Tumino, "Civile-M.P. Arezzo" Hospital, Ragusa; Salvatore Panico, Federico II University, Naples; Carlotta Sacerdote, Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica-Piemonte, Torino, Italy; José R. Quirós, Public Health and Health Planning Directorate, Asturias; Carlos A. Gonzáles, Catalan Institute of Oncology, Barcelona; Maria-José Sánchez, Andalusian School of Public Health and Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Granada; Miren Dorronsoro, Basque Regional Health Department and CIBERESP Biodonostia, San Sebastian; Carmen Navarro, Murcia Regional Health Council, Universidad de Murcia, and CIBERESP, Murcia; Aurelio Barricarte, Navarre Public Health Institute and CIBERESP, Pamplona, Sp

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.8190DOI Listing
May 2014

Interindividual variability of response to rituximab: from biological origins to individualized therapies.

Clin Cancer Res 2011 Jan;17(1):19-30

Service d'Hématologie, Centre Hospitalier Universitaire, Université Montpellier I, UMR CNRS5235, Université Montpellier II, France.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-1292DOI Listing
January 2011

Maintenance therapy for low-grade lymphomas: has the time come?

Curr Opin Oncol 2007 Sep;19(5):425-32

Service d'Hématologie Clinique, Centre Hospitalier Universitaire (CHU) de Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3282c9ad65DOI Listing
September 2007

Follicular Lymphoma International Prognostic Index.

Curr Treat Options Oncol 2006 Jul;7(4):270-5

Centre Jean Bernard, 9 rue Beauverger, 72000 Le Mans, France.

View Article

Download full-text PDF

Source
July 2006

Safety of rituximab maintenance therapy in follicular lymphomas.

Leuk Res 2006 Mar;30 Suppl 1:S16-21

Department of Hematology and Medical Oncology, Jean Bernard Cancer Centre, Le Mans, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(06)80004-4DOI Listing
March 2006

Prognosis of follicular lymphomas.

Clin Lymphoma 2005 Jun;6(1):21-5

Department of Hematology and Medical Oncology, Centre Jean Bernard, Le Mans, France.

View Article

Download full-text PDF

Source
June 2005

From the bench to the bedside: ways to improve rituximab efficacy.

Blood 2004 Nov 29;104(9):2635-42. Epub 2004 Jun 29.

UPRES-EA Immuno-Pharmaco-Génétique des Anticorps thérapeutiques, UPRES-EA, Université François Rabelais, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-03-1110DOI Listing
November 2004

[Monoclonal anti-CD20 antibody therapy].

Rev Prat 2004 Apr;54(7):711-2

Centre Jean Bernard, Le Mans.

View Article

Download full-text PDF

Source
April 2004

Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.

Haematologica 2003 Jul;88(7):811-23

Department of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

View Article

Download full-text PDF

Source
July 2003

Rituximab therapy for indolent non-Hodgkin's lymphoma.

Anticancer Drugs 2002 Nov;13 Suppl 2:S11-7

University Medical Center Utrecht, Department of Hematology, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
November 2002

Intensive therapies in follicular non-Hodgkin lymphomas.

Blood 2002 Aug;100(4):1141-52

Service des Maladies du Sang, Centre Hospitalo-Universitaire, Angers, France.

View Article

Download full-text PDF

Source
August 2002

Increasing treatment options in indolent non-Hodgkin's lymphoma.

Semin Oncol 2002 Apr;29(2 Suppl 6):2-6

Jean Bernard Cancer Centre, Le Mans, France.

View Article

Download full-text PDF

Source
April 2002

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Blood 2002 Feb;99(3):754-8

Service d'Oncologie Médicale et Maladies du Sang et Laboratoire d'Immunologie, Centre Hospitalier Régional et Universitaire de Tours, 37044 Tours Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.3.754DOI Listing
February 2002